| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,351 |
1,823 |
$97K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,266 |
1,888 |
$60K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,845 |
1,322 |
$35K |
| 62323 |
|
490 |
361 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
278 |
207 |
$18K |
| 77002 |
|
339 |
130 |
$16K |
| 20610 |
|
284 |
106 |
$15K |
| 76942 |
|
182 |
141 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
166 |
135 |
$6K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
780 |
616 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
57 |
54 |
$2K |
| 64450 |
|
22 |
13 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
36 |
25 |
$654.75 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
61 |
60 |
$633.40 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
217 |
99 |
$16.72 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
94 |
60 |
$0.00 |